Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy

References

• Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F. Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;48:82–118. doi:10.1016/j.preteyeres.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86:126–45. doi:10.1111/j.1600-0420.2007.00889.x.
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987;7:11–31. doi:10.1097/00006982-198700720-00009.
   Web of Science ®Google Scholar
• Tittl MK, Spaide RF, Wong D, Pilotto E, Yannuzzi LA, Fisher YL, Freund B, Guyer DR, Slakter JS, Sorenson JA. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol. 1999;128:63–68.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111:244–49. doi:10.1016/j.ophtha.2003.09.024.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Rumelt S, Melby J. Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology. 2003;110:698–703. doi:10.1016/S0161-6420(02)01975-9.
   PubMed Web of Science ®Google Scholar
• Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104:1653–60.
   PubMed Web of Science ®Google Scholar
• Miki A, Kondo N, Yanagisawa S, Bessho H, Honda S, Negi A. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology. 2014;121:1067–72. doi:10.1016/j.ophtha.2013.11.020.
   PubMed Web of Science ®Google Scholar
• de Jong K, Breukink MB, Schellevis RL, Bakker B, Mohr JK, Fauser S, Keunen JE, Hoyng CB, den Hollander AI, Boon CJ. Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration. Ophthalmology. 2015;122:562–70. doi:10.1016/j.ophtha.2014.09.026.
   PubMed Web of Science ®Google Scholar
• Moschos MM, Gazouli M, Gatzioufas Z, Brouzas D, Nomikarios N, Sivaprasad S, Mitropoulos P, Chatziralli IP. Prevalence of the complement factor H and GSTM1 genes polymorphisms in patients with central serous chorioretinopathy. Retina. 2016;36:402–07. doi:10.1097/IAE.0000000000000693.
   PubMed Web of Science ®Google Scholar
• Breukink MB, Schellevis RL, Boon CJ, Fauser S, Hoyng CB, den Hollander AI, de Jong EK. Genomic copy number variations of the complement component C4B gene are associated with chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci. 2015;56:5608–13. doi:10.1167/iovs.15-17343.
   PubMed Web of Science ®Google Scholar
• Schubert C, Pryds A, Zeng S, Xie Y, Freund KB, Spaide RF, Merriam JC, Barbazetto I, Slakter JS, Chang S. Cadherin5 is regulated by corticosteroids and associated with central serous chorioretinopathy. Hum Mutat. 2014;35:859–67. doi:10.1002/humu.22551.
   PubMed Web of Science ®Google Scholar
• van Dijk EHC, Schellevis RL, van Bergen MGJM, Breukink MB, Altay L, Scholz P, Fauser S, Meijer OC, Hoyng CB, den Hollander AI. Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy. JAMA Ophthalmol. 2017;135:446–51. doi:10.1001/jamaophthalmol.2017.0245.
   PubMed Web of Science ®Google Scholar
• Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye. 1995;9:324–32. doi:10.1038/eye.1995.63.
   PubMed Web of Science ®Google Scholar
• Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina. 1999;19:508–12.
   PubMed Web of Science ®Google Scholar
• Kitaya N, Nagaoka T, Hikichi T, Sugawara R, Fukui K, Ishiko S, Yoshida A. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol. 2003;87:709–12.
   PubMed Web of Science ®Google Scholar
• Yamada R, Yamada S, Ishii A, Tane S. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi. 1993;97:955–60.
   PubMedGoogle Scholar
• Iijima H, Iida T, Murayama K, Imai M, Gohdo T. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol. 1999;127:477–78.
   PubMed Web of Science ®Google Scholar
• Sogutlu Sari E, Yazici A, Eser B, Erol MK, Kilic A, Ermis SS, Koytak A, Akşit H, Yakut T. The prevalence of 4G/5G polymorphism of plasminogen activator-1 (PAI-1) gene in central serous chorioretinopathy and its associations with plasma PAI-1 levels. Cutan Ocul Toxicol. 2014;33:270–74. doi:10.3109/15569527.2013.854372.
   PubMed Web of Science ®Google Scholar
• Ladenvall P, Wall U, Jern S, Jern C. Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo. Thromb Haemost. 2000;84:150–55.
   PubMed Web of Science ®Google Scholar
• Dawson S, Hamsten A, Wilman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183–90.
   PubMed Web of Science ®Google Scholar
• Oszajca K, Wroński K, Janiszewska G, Bieńkiewicz M, Bartkowiak J, Szemraj J. The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm. Mol Biol Rep. 2014;41:2859–64. doi:10.1007/s11033-014-3141-6.
   PubMed Web of Science ®Google Scholar
• Dupont WD. Plummer WD: PS power and sample size program available for free on the Internet. Controlled Clin Trials. 1997;18:274. doi:10.1016/S0197-2456(97)00074-3.
   Google Scholar
• Margaglione M, Cappucci G, d` Addedda M, Colaizzo D, Giuliani N, Vecchione G, Mascolo G, Grandone E, Di Minno G. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis. Relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol. 1998;18:562–67.
   PubMed Web of Science ®Google Scholar
• Manly KF, Nettleton D, Hwang JT. Genomics, prior probability, and statistical tests of multiple hypotheses. Genome Res. 2004;14:997–1001. doi:10.1101/gr.2156804.
   PubMed Web of Science ®Google Scholar
• Miettinen OS. Up from “false positives” in genetic-and other-epidemiology. Eur J Epidemiol. 2009;24:1–5. doi:10.1007/s10654-008-9295-6.
   PubMed Web of Science ®Google Scholar